Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

Share Price is delayed by 15 minutes
Get Live Data
2,372.00    -66.00 (-2.71%)
Bid:
2,372.00
Ask:
2,376.00
Spread: 4.00 (0.169%)
Market Cap: £6.16b
WEIR Live PriceLast checked at - London Stock Exchange

Intraday Weir Group Share Chart

Director/PDMR Shareholding

24 Aug 2009 16:31

RNS Number : 9199X
Weir Group PLC
24 August 2009
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING

MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

This form is intended for use by anΒ issuerΒ to make aΒ RISΒ notification required byΒ DRΒ 3.1.4R(1).

(1) AnΒ issuerΒ making a notification in respect of a transaction relating to theΒ sharesΒ or debentures of theΒ issuerΒ should completeΒ boxes 1 to 16, 23 and 24.

(2) AnΒ issuerΒ making a notification in respect of a derivative relating theΒ sharesΒ of theΒ issuerΒ should completeΒ boxes 1 to 4, 6, 8,Β 13, 14, 16, 23 and 24.

(3) AnΒ issuerΒ making a notification in respect of options granted to aΒ director/person discharging managerial responsibilitiesΒ should completeΒ boxes 1 to 3Β and 17 to 24.

(4) AnΒ issuerΒ making a notification in respect of aΒ financial instrumentΒ relating to theΒ sharesΒ of theΒ issuerΒ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Please complete all relevant boxes should in block capital letters.

1.

Name of theΒ issuer

THE WEIR GROUP PLC

2.

State whether the notification relates to (i) a transaction notified in accordance withΒ DRΒ 3.1.4R(1)(a); or

(ii)Β DRΒ 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

(iii) both (i) and (ii)

(i)Β 

3.

Name ofΒ person discharging managerial responsibilities/director

KEITH COCHRANE

4.

State whether notification relates to aΒ personΒ connected with aΒ person discharging managerial responsibilities/directorΒ named in 3 and identify theΒ connected person

FIONA COCHRANE

5.

Indicate whether the notification is in respect of a holding of theΒ personΒ referred to in 3 or 4 above or in respect of a non-beneficial interest

3Β AND 4Β ABOVE

6.

Description ofΒ sharesΒ (includingΒ class), debentures or derivatives or financial instruments relating toΒ shares

ORDINARY SHARES OF 12.5P EACH

7.

Name of registered shareholders(s) and, if more than one, the number ofΒ sharesΒ held by each of them

KEITH COCHRANE 9,623

KEITH COCHRANE 100

KEITH COCHRANE 100

8.

State the nature of the transaction

EXERCISE OF AN AWARDΒ UNDER THE GROUP LONG TERM INCENTIVE PLANΒ AND SUBSEQUENTΒ SALEΒ OF SUFFICIENT SHARES TO SATISFY THE TAX LIABILITYΒ AND THE TRANSFER OF THE BALANCE TO HIS SPOUSE FIONA COCHRANE.

9.

Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ acquired

KEITH COCHRANE 53,011

10.

Percentage of issuedΒ classΒ acquired (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)

N/A

11.

Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ disposed

KEITH COCHRANE 53,011

12.

Percentage of issuedΒ classΒ disposed (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)

N/A

13.

Price perΒ shareΒ or value of transactionΒ 

AWARD MADE AT NIL COST ONΒ 24 AUGUST 2009

SHARE DISPOSALΒ FOR SETTLEMENT OF TAXΒ TRANSACTED ATΒ 657.4492Β p

SHARE TRANSFER TO SPOUSE AT NIL COST

14.

Date and place of transaction

24 August 2009

15.

Total holding following notification and total percentage holding following notification (anyΒ treasury sharesΒ should not be taken into account when calculating percentage)

KEITH COCHRANE 9,623

KEITH COCHRANE 100

KEITH COCHRANE 100

FIONA COCHRANE 31,843

16.

Date issuer informed of transaction

24 August 2009

If aΒ person discharging managerial responsibilitiesΒ has been granted options by theΒ issuerΒ complete the following boxes

17.

Date of grant

18.

Period during which or date on which it can be exercised

19.

Total amount paid (if any) for grant of the option

20.

Description ofΒ sharesΒ or debentures involved (classΒ and number)

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number ofΒ sharesΒ or debentures over which options held following notification

23.

Any additional information

24

Name of contact and telephone number for queries

FRANCES MCCAW

0141 308 3737

Name and signature of duly authorised officer ofΒ issuerΒ responsible for making notification

………………FRANCES MCCAW………………………………………………

Date of notification ……………24 August 2009…………...……………………..

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSPIMATMMTTBLL
Date   Source Headline
1st Jun 20262:45 pmRNSDirector/PDMR Shareholding
15th May 20269:16 amRNSHolding(s) in Company
13th May 20268:47 amRNSHolding(s) in Company
11th May 20269:50 amRNSDirector/PDMR Shareholding
8th May 20261:06 pmRNSDirector/PDMR Shareholding
8th May 20268:23 amRNSHolding(s) in Company
30th Apr 20264:24 pmRNSResult of AGM
30th Apr 20267:01 amRNSCEO Succession Announcement
30th Apr 20267:00 amRNSQ1 Trading Update
21st Apr 20262:20 pmRNSDirector/PDMR Shareholding
21st Apr 20262:16 pmRNSDirector/PDMR Shareholding
21st Apr 20262:14 pmRNSDirector/PDMR Shareholding
15th Apr 20264:17 pmRNSDirector/PDMR Shareholding
14th Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20262:48 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 202610:37 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirectorate change
31st Mar 20264:10 pmRNSDirector/PDMR Shareholding
26th Mar 20267:34 amRNSHolding(s) in Company
23rd Mar 202612:06 pmRNS2025 Annual Report and 2026 Annual General Meeting
10th Mar 20269:57 amRNSDirector Declaration
6th Mar 20267:56 amRNSHolding(s) in Company
4th Mar 20262:01 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSWeir completes acquisition of ESEL
2nd Mar 20266:23 pmRNSHolding(s) in Company
16th Feb 20263:53 pmRNSHolding(s) in Company
30th Jan 20262:58 pmRNSHolding(s) in Company
26th Jan 202610:00 amRNS-RWeir receives 'A' score from CDP
14th Jan 20263:26 pmRNS-RWeir and Olayan announce key milestone
15th Dec 20258:36 amRNSDirectorate change
12th Dec 202510:30 amRNSWeir to acquire ESEL
4th Dec 20258:49 amRNSDirector Declaration
3rd Dec 20257:00 amRNSWeir Capital Markets Event
19th Nov 202510:02 amRNSDirector Declaration
11th Nov 20257:00 amRNSWeir completes acquisition of Fast2Mine
5th Nov 202512:20 pmRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNSQ3 Trading Update
16th Oct 20251:48 pmRNSNotification of Change in Director’s Details
16th Oct 202512:00 pmRNSWeir AUD 400m Bond Pricing
23rd Sep 202512:00 pmRNSWeir to acquire Fast2Mine
22nd Sep 20254:05 pmRNSHolding(s) in Company
22nd Sep 20259:08 amRNSHolding(s) in Company
28th Aug 20255:56 pmRNSDirector/PDMR Shareholding
28th Aug 20255:39 pmRNSWeir completes acquisition of Townley
5th Aug 20253:42 pmRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report
23rd Jul 20257:00 amRNS-RWeir retains CDP A score for climate transparency
30th Jun 202511:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.